Woodcliff Lake-based Par Pharmaceutical Companies Inc. announced Tuesday the appointment of Terrance J. Coughlin as its new chief operating officer.According to the announcement, Coughlin will be responsible for the company’s global manufacturing activities, research and development efforts, and new product selection.
He most recently was president and CEO at Glenmark Generics Inc. USA/Glenmark Generics Limited, Par announced in a recent press release.
ALSO ON NJBIZ:
California company Terra Tech setting up infrastructure in anticipation of N.J. marijuana legalization
N.J. gives Tesla two more weeks to comply with dealer regulations
Most-read March 31: When shouldn’t you file a property tax appeal?